| 1 |
Effects of genome architecture and epigenetic factors on susceptibility of promoter CpG islands to aberrant DNA methylation induction. (GSE28284) |
[Oligo Array] Agilent-014791 Human CpG Island ChIP-on-Chip Microarray 244K (G4492A) (Feature Number version) (GPL4126) |
National Cancer Center Research Institute |
2011-03-31 |
Homo sapiens
 |
4,626,576 (243,504 x 19)
|
|
|
|
4 |
|
|
|
|
|
9 |
|
|
|
|
|
|
|
|
6 |
by_platform by_series |
| 2 |
Whole genome expression array profiling highlights differences in mucosal defense genes in Barrett's esophagus and esophageal adenocarcinoma. (GSE28302) |
[Bead Array] Sentrix Human-6 Expression BeadChip (GPL2507) |
Queensland Institute of Medical Research |
2011-03-31 |
Homo sapiens
 |
2,553,822 (47,293 x 54)
|
|
|
|
|
|
54 |
|
|
|
|
|
|
|
|
|
|
|
|
|
by_platform by_series |
| 3 |
Microarray-based identification of age-dependent differences in gene expression of human dermal fibroblasts (GSE28300) |
[Oligo Array] Agilent-014850 Whole Human Genome Microarray 4x44K G4112F (Feature Number version) (GPL4133) |
LUMC |
2011-03-31 |
Homo sapiens
 |
1,627,920 (45,220 x 36)
|
|
|
36 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
by_platform by_series |
| 4 |
Effects of genome architecture and epigenetic factors on susceptibility of promoter CpG islands to aberrant DNA methylation induction. (GSE28284) |
[Oligo Array] Agilent-014791 Human CpG Island ChIP-on-Chip Microarray 244K (G4492A) (Probe Name version) (GPL9767) |
National Cancer Center Research Institute |
2011-03-31 |
Homo sapiens
 |
1,204,845 (240,969 x 5)
|
|
|
|
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
2 |
by_platform by_series |
| 5 |
Transcription profiling of Rab25 transfected ovarian A2780 cancer cell (GSE28299) |
[GeneChip] [U133AAofAv2] Affymetrix GeneChip HT-HG_U133A Early Access Array (GPL4685) |
UT-MD Anderson Cancer Center |
2011-03-31 |
Homo sapiens
 |
550,656 (22,944 x 24)
|
|
8 |
|
16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
by_platform by_series |
| 6 |
Effects of genome architecture and epigenetic factors on susceptibility of promoter CpG islands to aberrant DNA methylation induction. (GSE28284) |
[GeneChip] [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array (GPL570) |
National Cancer Center Research Institute |
2011-03-31 |
Homo sapiens
 |
109,350 (54,675 x 2)
|
|
|
|
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
|
1 |
by_platform by_series |
| 7 |
Genome-wide analysis of transcription factor E2F1 mutant proteins reveals that N- and C-terminal protein interaction domains do not participate in targeting E2F1 to the human genome. (GSE28286) |
[HT Sequencing] Illumina Genome Analyzer (Homo sapiens) (GPL9052) |
Stanford University |
2011-03-31 |
Homo sapiens
 |
9 (0 x 9)
|
|
|
|
|
|
|
|
|
|
9 |
|
|
|
|
|
|
|
|
|
by_platform by_series |
| 8 |
An East-Asian polymorphism underlies BCR-ABL mutation-independent resistance to tyrosine kinase inhibitors in chronic myelogenous leukemia (GSE28303) |
[HT Sequencing] AB SOLiD System 2.0 (Homo sapiens) (GPL9138) |
Genome Institute of Singapore |
2011-03-31 |
Homo sapiens
 |
5 (0 x 5)
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
by_platform by_series |
| 9 |
An East-Asian polymorphism underlies BCR-ABL mutation-independent resistance to tyrosine kinase inhibitors in chronic myelogenous leukemia (GSE28303) |
[HT Sequencing] AB SOLiD System 3.0 (Homo sapiens) (GPL9442) |
Genome Institute of Singapore |
2011-03-31 |
Homo sapiens
 |
1 (0 x 1)
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
by_platform by_series |
| 10 |
Isocitrate dehydrogenase 1 (IDH1) mutant gliomas demonstrate a distinct global CpG island methylation profile compared to IDH1 wildtype gliomas using MRSE (GSE28271) |
[Oligo Array] Agilent 45K CpG Island microarrays (GPL13349) |
UCLA |
2011-03-30 |
Homo sapiens
 |
1,803,760 (45,094 x 40)
|
40 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
by_platform by_series |
| 11 |
Genome-wide analysis of Prokineticin-1-regulated genes in human term myometrium (GSE28272) |
[Bead Array] Illumina HumanHT-12 V3.0 expression beadchip (GPL6947) |
MRC Human Reproductive Sciences Unit |
2011-03-30 |
Homo sapiens
 |
1,171,272 (48,803 x 24)
|
|
|
|
24 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
by_platform by_series |
| 12 |
Real-time Monitoring of Cisplatin Toxicity on Cancer Cells (GSE28274) |
[GeneChip] [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array (GPL570) |
University Heidelberg |
2011-03-30 |
Homo sapiens
 |
328,050 (54,675 x 6)
|
|
|
|
|
|
|
|
|
|
6 |
|
|
|
|
|
|
|
|
|
by_platform by_series |
| 13 |
Expression data from BJ-hTERT cells expressing vector, Cyclin E, c-Myc or coexpression of both (GSE28266) |
[GeneChip] [HuGene-1_0-st] Affymetrix Human Gene 1.0 ST Array [transcript (gene) version] (GPL6244) |
The Hebrew University of Jerusalem |
2011-03-30 |
Homo sapiens
 |
233,079 (33,297 x 7)
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 |
by_platform by_series |
| 14 |
Loss of cytoplasmic CDK1 predicts poor survival in human lung cancer and confers chemotherapeutic resistance (GSE28282) |
[cDNA Array] NHGRI Human 30k cDNA array (GPL13354) |
NCI |
2011-03-30 |
Homo sapiens
 |
80,835 (26,945 x 3)
|
|
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
by_platform by_series |
| 15 |
Differential expression of microRNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells (GSE28267) |
[Oligo Array] miRCURY LNA microRNA Array, v.11.0 - hsa, mmu & rno (GPL7723) |
University of Louisville School of Medicine |
2011-03-30 |
Homo sapiens
 |
28,042 (2,003 x 14)
|
|
|
|
|
|
|
|
|
|
14 |
|
|
|
|
|
|
|
|
|
by_platform by_series |
| 16 |
Renal cortex microRNA expression differences between hypertensive and normotensive patients (GSE28283) |
[Oligo Array] Agilent-021827 Human miRNA Microarray (V3) (miRBase release 12.0 miRNA ID version) (GPL10850) |
University of Sydney |
2011-03-30 |
Homo sapiens
 |
7,832 (979 x 8)
|
|
|
|
|
|
|
|
|
8 |
|
|
|
|
|
|
|
|
|
|
by_platform by_series |
| 17 |
Differential expression of microRNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells (GSE28267) |
[Oligo Array] miRCURY LNA microRNA Array, v.10.0 - hsa, mmu & rno (GPL7722) |
University of Louisville School of Medicine |
2011-03-30 |
Homo sapiens
 |
7,674 (1,279 x 6)
|
|
|
|
|
|
|
|
|
|
6 |
|
|
|
|
|
|
|
|
|
by_platform by_series |
| 18 |
NKX3-1, a Novel Transcriptional Factor of AR, Promotes Prostate Cancer Cell Survival via RAB3B GTPase-mediated protein trafficking (GSE28264) |
[HT Sequencing] Illumina Genome Analyzer II (Homo sapiens) (GPL9115) |
Genome Institute of Singapore (GIS) |
2011-03-30 |
Homo sapiens
 |
9 (0 x 9)
|
|
|
|
9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
by_platform by_series |
| 19 |
Human medulloblastoma samples (GSE28245) |
[Oligo Array] Agilent-014850 Whole Human Genome Microarray 4x44K G4112F (Probe Name version) (GPL6480) |
German Cancer Research Center |
2011-03-29 |
Homo sapiens
 |
2,630,016 (41,094 x 64)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
64 |
|
by_platform by_series |
| 20 |
Peripheral blood lymphocytes: ALS patients vs. healthy controls (GSE28253) |
[Oligo Array] Agilent-014850 Whole Human Genome Microarray 4x44K G4112F (Feature Number version) (GPL4133) |
Carolinas Medical Center |
2011-03-29 |
Homo sapiens
 |
994,840 (45,220 x 22)
|
|
22 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
by_platform by_series |